A second course of high-dose melphalan and auto-SCT for the treatment of relapsed AL amyloidosis. [electronic resource]
Producer: 20111212Description: 976-80 p. digitalISSN:- 1476-5365
- Adult
- Amyloidosis -- drug therapy
- Cohort Studies
- Disease-Free Survival
- Female
- Hematopoietic Stem Cell Mobilization -- methods
- Hematopoietic Stem Cell Transplantation -- methods
- Humans
- Immunoglobulin Light-chain Amyloidosis
- Kaplan-Meier Estimate
- Male
- Melphalan -- administration & dosage
- Middle Aged
- Recurrence
- Survival Analysis
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.